Skip to main content
Top

Cancer Chemotherapy and Pharmacology

1997 - 2024
Volumes
340
Issues
Chevron right icon
Issue 5/2024
Latest issue

Cancer Chemotherapy and Pharmacology OnlineFirst articles

About this journal

Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials.

The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.

Metadata
Title
Cancer Chemotherapy and Pharmacology
Coverage
Volume 39/1997 - Volume 93/2024
Publisher
Springer Berlin Heidelberg
Electronic ISSN
1432-0843
Print ISSN
0344-5704
Journal ID
280
DOI
https://doi.org/10.1007/280.1432-0843
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine